The Budget reframes healthcare as a strategic national capability, backing biopharma innovation, workforce expansion and technology-led governance to power India's next growth phase.
Israel and the United States had a plan. Iran punched back. And now the Gulf is reeling, the world is beginning to feel the pain and, as on date, no one in Washington or Tel Aviv appears willing to admit that the punch has landed, notes Prem Panicker, continuing his must-read blog on the war in the Middle East.
Securities and Exchange Board of India (Sebi) Chairman Tuhin Kanta Pandey on Thursday called for sharper disclosures in IPO (initial public offering) offer documents, particularly around risk factors, valuation rationale, objects of the issue, and utilisation of proceeds.
Experts warn of the dangers of online gaming addiction among adolescents, citing limited social interaction, blurred realities and the potential for tragic outcomes. Recent incidents highlight the need for awareness and intervention.
Spiritual orator Aniruddhacharya on Monday lauded BCCI's directive for IPL team Kolkata Knight Riders (KKR) to release Bangladeshi cricketer Mustafizur Rahman
Traffic on the Mumbai-Pune Expressway resumed at 1.46 am after the damaged gas tanker was shifted from the accident site, an official said.
The government on Sunday gave a strong push to upgradation and expansion of healthcare infrastructure, medical education and pharma sector with the Union Budget 2026-27 announcing a slew of steps, including those aimed at making India a global hub for allied healthcare professionals and biopharma manufacturing.
Following the notification allowing 100 per cent foreign direct investment (FDI) in the insurance sector, the Finance Ministry has revised norms to remove the requirement that a majority of directors and key management personnel in an insurance company with foreign investment be Indian residents.
'We should learn from the wild world on how they live harmoniously.'
The insurance industry is trying to get to grips with provisions in the proposed Insurance Amendment Bill, which gives additional powers to the Insurance Regulatory and Development Authority of India (Irdai), while there is ambiguity in the very definition of the insurance business, according to industry experts.
KKR acquired the left-arm pacer for Rs 9.20 crore (Rs 92 million) at last month's IPL mini auction in Abu Dhabi, making him the most expensive Bangladeshi player in IPL history.
Domestic carrier IndiGo has cancelled over 180 flights from three major airports on Thursday, as the Gurugram-based airline struggles to secure the required crew to operate its flights in the wake of new flight-duty and rest-period norms for pilots.
Mundane as it may seem, this is in some ways a metaphor for the challenges facing the nation, argue Arvind Subramanian and Devesh Kapur in their new book, A Sixth Of Humanity.
The board of InterGlobe Aviation, the parent of IndiGo, has already set up a crisis management group in the wake of the significant operational disruptions that started on December 2.
'The real story of 2025 is that India officially stopped being a 'market of the future' and started acting as the world's primary economic engine.'
'Neither SAI nor state departments have a dedicated sports administration service. Instead, roles are filled by generalist civil servants or contractual staff, often lacking sector-specific expertise.'
Taking paracetamol is something that deserves careful attention and should not be done too casually or too often.
The Indian government has introduced a bill to overhaul the civil nuclear sector, allowing private participation and establishing a new liability regime. The SHANTI Bill, 2025, aims to repeal existing acts and address industry concerns.
The Supreme Court of India is considering formulating pan-India guidelines to prevent road accidents on expressways and national highways, following a fatal accident in Rajasthan. The court is focusing on the issue of illegal 'dhabas' and encroachments along highways as potential causes of accidents.
The Central Drugs Standard Control Organisation (CDSCO) has initiated a nationwide campaign to test, inspect, and audit cough syrup manufacturers following concerns about contaminated products and child deaths. The initiative aims to ensure adherence to safety standards and regulatory compliance.
Days after an outage at MCX, Sebi chairman Tuhin Kanta Pandey on Tuesday expressed his displeasure over "repeated" instances of breakdowns at exchanges.
'Developers have started offering 70% to 100% extra area and beyond.' 'If the market cycle shifts -- as many are already predicting with signs of price saturation and reduction -- most recent redevelopment projects will unravel.'
Where was the Board when a predictable regulatory change brought the country's largest airline to its knees? asks Dr Sudhir Bisht.
This is what the new Spanish study reveals about a woman's brain after sexual assault.
The Central Drugs Standard Control Organisation (CDSCO) will conduct testing, inspection and auditing of cough syrup manufacturers.
'Don't look at Russia only as a place to earn quickly and then leave.' 'Try to build experience in serious companies, skills and certifications that will serve you anywhere in the world.'
'In the long run, India's strong growth story and reforms to make assets globally attractive will determine the rupee's resilience.'
India's drug regulator CDSCO has recalled three cough syrups and halted their production after the WHO raised concerns about potential contamination and links to child deaths. The WHO is investigating reports of pediatric illnesses and deaths in India potentially linked to contaminated syrups.
Turkish President Recep Tayyip Erdogan's anti-tobacco crusade has a new target: Italian Prime Minister Giorgia Meloni, Politico reported.
'Instead of the government and telecom operators solving the mess of their own creation, they're telling us we need to give access to our phones perpetually.'
In 1997, the seven-judge bench ruled that the Centre had the regulatory power over the production of industrial alcohol. The case was referred to the nine-judge bench in 2010.
Canadian firm Manulife and Mahindra & Mahindra (M&M), an Indian automaker with interests in financial services, have signed an agreement to form a 50:50 life insurance joint venture (JV) with a total capital commitment of up to Rs 3,600 crore each totalling Rs 7,200 crore.
'Even as the Supreme Court's anti-punitive demolition judgment nears its first anniversary, no formal contempt proceedings have been initiated either by the Supreme Court or any high court against officers or demolition squads who have acted in violation of it.'
IPL chairman Arun Dhumal spoke on the BCCI finally having started the "ball rolling" as far as finding a new lead sponsor for Team India is concerned
Clarity on Tata Sons' position on listing, as of 2025, would help define the future of the group better, irrespective of the RBI stand. As of now, the ball is in the RBI's court, and everyone is watching the space, points out Nivedita Mookerji.
'Amazon, Meta, Google, Microsoft have large operations in India and rely on smooth trade and data flows.' 'Restrictions could raise their costs, limit AI chip exports, and complicate their India strategies.'
Finance Minister Nirmala Sitharaman on Tuesday asked fintech firms to focus on risk management at a time when criminals are using AI to mimic voices, clone identities and create lifelike videos to manipulate people.
'If a parent was diagnosed at 50, the child should start screenings 5 to 10 years earlier (around 35 to 40).' 'Awareness of family history and age of onset helps catch the disease early.'
Who else will take on the might of Microsoft, Google, and Amazon if not the Adanis, Ambanis, Birlas, or Tatas?, asks R Jagannathan.
In 2023, the BCCI announced a deal with Dream11 as the lead sponsor for Team India. Dream11 replaced Byju's, whose contract ended in March that year, and had signed the agreement with BCCI for a period of three years.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances